News and Reports
Stay Updated
For all press requests, please reach out to [email protected].
News and Reports
News and Reports
Forbes: Medicare Negotiations For Next Round Of 15 Drugs Could Lead To Large Price Drops
According to the advocacy group, Patients for Affordable Drugs, several of the selected medicines saw substantial list price hikes last month, including Cimzia, Entyvio and Xeljanz, which increased by $899, $748 and $334, respectively. However, if data on list prices for drugs selected in the first and second rounds are any indicator, it’s expected that […]
News and Reports
India Currents: Why Do 47% of Americans Worry They Cannot Pay For Healthcare?
“The reality is that 1 in 3 Americans and people in this country cannot afford to pay for their prescription drugs,” said Merith Basey, Patients For Affordable Drugs. Americans are paying between 4 and 8 times, on average, what patients in other high-income countries are paying for the same brand-name drugs.
News and Reports
North Dallas Gazette: Would Senate Passage of ACA Subsidies Band-Aid a Broken System?
One in three Americans cannot afford their prescriptions, noted Merith Basey of Patients for Affordable Drugs, and they pay between 4 and 8 times more than other high-income countries. Many countries negotiate drug prices, noted Basey, though the powerful American pharmaceutical industry has prevented Medicare from negotiating prices for over 20 years despite that they […]
News and Reports
Epoch Times: Botox, 14 Other Drugs to Be Negotiated by Medicare This Year
Merith Basey, CEO of advocacy group Patients for Affordable Drugs, said the negotiation program is effective at lowering prices. “As negotiations continue, millions more people on Medicare stand to benefit,” Basey said in a Jan. 28 statement. “Nobody should have to choose between life-saving drugs and their basic needs.”
News and Reports
India Post News: How Soaring Costs Are Reshaping Health Care Access?
Merith Basey, Executive Director, Patients for Affordable Drugs stated that the persistently high drug prices in the United States are primarily due to pharmaceutical companies maintaining market monopolies through the patent system. Drug prices are entirely set by the pharmaceutical companies themselves, with a lack of government negotiation mechanisms. She pointed out that research shows […]
News and Reports
KTVU Fox: Costs Reshaping Healthcare Forum As ACA Subsidies Expire
The speakers included Stanford University Professor of economics doctor Neil Mahoney and Merith Basey with Patients For Affordable Drugs, who talked about increasing prescription drug prices.
News and Reports
WRTV Indianapolis: Scammers take advantage of popularity of GLP-1 drugs
As the Better Business Bureau tracks complaints about GLP-1-related scams, Patients for Affordable Drugs is tracking GLP-1 prices. The national patient advocacy organization says the injectables are still too costly for many Americans. “The issue is largely driven by the power of the pharmaceutical industry and the monopoly power they have over setting prices,” said […]